Divi's Laboratories Ltd
NSE:DIVISLAB
Relative Value
The Relative Value of one DIVISLAB stock under the Base Case scenario is 3 570.02 INR. Compared to the current market price of 3 911.4 INR, Divi's Laboratories Ltd is Overvalued by 9%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
DIVISLAB Competitors Multiples
Divi's Laboratories Ltd Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
IN |
Divi's Laboratories Ltd
NSE:DIVISLAB
|
1T INR | 13.9 | 75.1 | 51.3 | 62.9 | ||
US |
Thermo Fisher Scientific Inc
NYSE:TMO
|
221.5B USD | 5.2 | 36.9 | 22.9 | 33.6 | ||
US |
Danaher Corp
NYSE:DHR
|
184.2B USD | 4.2 | 22.8 | 16.6 | 20.4 | ||
US |
IQVIA Holdings Inc
NYSE:IQV
|
41.6B USD | 2.8 | 30.6 | 16.7 | 25.8 | ||
CH |
Lonza Group AG
SIX:LONN
|
37.6B CHF | 5.6 | 57.5 | 19.8 | 29 | ||
KR |
Samsung Biologics Co Ltd
KRX:207940
|
55.9T KRW | 15.1 | 65.1 | 34.3 | 49.5 | ||
US |
Agilent Technologies Inc
NYSE:A
|
41.4B USD | 6.1 | 33.5 | 26.8 | 32.3 | ||
US |
West Pharmaceutical Services Inc
NYSE:WST
|
26.9B USD | 9.2 | 47.3 | 32.5 | 39.5 | ||
US |
Mettler-Toledo International Inc
NYSE:MTD
|
26.9B USD | 7.1 | 34.1 | 23.8 | 26.5 | ||
IE |
ICON PLC
NASDAQ:ICLR
|
26.2B USD | 3.2 | 38.1 | 17.3 | 26.6 | ||
FR |
Sartorius Stedim Biotech SA
PAR:DIM
|
19.2B EUR | 7.1 | 75.3 | 32.4 | 53.2 |